Clinical Trial: The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Multicenter Prospective Study on the Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants
Brief Summary:
Thirteen hospitals in China will participate in the study, which aims to provide data on serum bilirubin levels in the first 168 hr after birth in term and late-preterm neonates, and estimate the incidence of severe neonatal hyperbilirubinemia and the underlying causes.
We hypothesize that the study can be value in identifying and implementing strategies for risk reduction.
Detailed Summary:
Neonatal hyperbilirubinemia resulting in clinical jaundice is a common problem among infants, particularly during the first weeks of life.
Information about the incidence and risk factors of neonatal jaundice is not available from China where is one of the highest countries of the incidence of severe neonatal hyperbilirubinemia.
Sponsor: Nanjing Medical University
Current Primary Outcome: The incidence of severe neonatal hyperbilirubinemia [ Time Frame: At the 28 days after birth ]
Original Primary Outcome: The incidence of severe neonatal hyperbilirubinemia [ Time Frame: At the 28 days after birth ]
Current Secondary Outcome: Number of participants with risk factors associated with severe neonatal hyperbilirubinemia [ Time Frame: At the 28 days after birth ]
Original Secondary Outcome: Number of participants with risk factors associated with severe neonatal hyperbilirubinemia [ Time Frame: At the 28 days after birth ]
Information By: Nanjing Medical University
Dates:
Date Received: January 2, 2013
Date Started: January 2013
Date Completion:
Last Updated: October 25, 2014
Last Verified: October 2014